-
Supported By:

Subscribe or Follow
Program on Corporate Governance Advisory Board
- Peter Atkins
- David Bell
- Kerry E. Berchem
- Richard Brand
- Daniel Burch
- Paul Choi
- Jesse Cohn
- Arthur B. Crozier Christine Davine
- Renata J. Ferrari
- Andrew Freedman
- Ray Garcia
- Byron Georgiou
- Joseph Hall
- Jason M. Halper William P. Mills
- David Millstone
- Theodore Mirvis
- Philip Richter
- Elina Tetelbaum
- Sebastian Tiller
- Marc Trevino Jonathan Watkins
- Steven J. Williams
HLS Faculty & Senior Fellows
Author Archives: Harvard Law School Forum on Corporate Governance and Financial Regulation
Recent SPAC Shareholder Suits in New York State Courts: The Beginning Wave of SPAC Litigation
Key Points Between September 2020 and March 2021, at least 35 SPACs have been hit with one or more shareholder lawsuits filed in New York state court. These lawsuits generally allege that SPAC directors breached their fiduciary duties to shareholders by providing allegedly inadequate disclosures regarding proposed de-SPAC mergers. Some of these lawsuits also assert […]
Click here to read the complete post
Posted in Court Cases, Mergers & Acquisitions, Practitioner Publications, Securities Litigation & Enforcement
Tagged IPOs, Merger litigation, Mergers & acquisitions, New York, Shareholder suits, SPACs, State law
Comments Off on Recent SPAC Shareholder Suits in New York State Courts: The Beginning Wave of SPAC Litigation
Weekly Roundup: April 16–22, 2021
Interest in SPACs is Booming…and So is the Risk of Litigation Posted by Stephen Fraidin, Gregory P. Patti, Jr. and Jason Halper, Cadwalader, Wickersham & Taft LLP, on Friday, April 16, 2021 Tags: Boards of Directors, Capital formation, Merger litigation, Mergers & acquisitions, Proxy disclosure, SEC, SEC enforcement, Securities litigation, SPACs Statement by Commissioner Peirce on Rethinking Global ESG Metrics Posted by Hester M. Peirce, […]
Click here to read the complete postA New Theory of Material Adverse Effects
In a paper forthcoming in Business Lawyer, I propose a new, systematic understanding of material adverse effects that resolves the major outstanding problems in the Delaware caselaw on MAEs. As is well known, business combination agreements almost never define the phrase “material adverse effect,” and so the meaning of that key expression derives primarily from […]
Click here to read the complete post
Posted in Academic Research, Mergers & Acquisitions, Securities Litigation & Enforcement
Tagged Adverse effects, Delaware articles, Delaware cases, Delaware law, Derivative suits, Materiality, Merger litigation, Mergers & acquisitions, Shareholder suits
Comments Off on A New Theory of Material Adverse Effects
The Giant Shadow of Corporate Gadflies
Modern-day shareholders influence corporate America more than ever before. From demanding greater accountability of executives to lobbying for a variety of social and environmental policies, shareholders today have the power to alter how American companies are run. Indeed, much attention has been directed towards the rise of large institutional investors and their influence on corporate […]
Click here to read the complete postHow Much Do We Trust Staggered Difference-in-Differences Estimates?
Difference-in-differences (DiD) has been the workhorse statistical methodology for analyzing regulatory or policy effects in applied finance, law, and accounting research. A generalized version of this estimation approach that relies on the staggered adoption of regulations or policies (e.g., across states or across countries) has become especially popular over the last two decades. For example, […]
Click here to read the complete post
Posted in Academic Research, Accounting & Disclosure, Empirical Research, Financial Regulation
Tagged Accounting, Data science, Econometrics, Financial regulation
Comments Off on How Much Do We Trust Staggered Difference-in-Differences Estimates?
The Activism Vulnerability Report Q4 2020
Introduction & Market Update FTI Consulting’s Activism and M&A Solutions team welcomes our clients, friends and readers to our sixth quarterly Activism Vulnerability Report, documenting the results of our Activism Vulnerability Screener from the recent fourth quarter of 2020, as well as other notable trends and themes in the world of shareholder activism and engagement. […]
Click here to read the complete post
Posted in Boards of Directors, Corporate Elections & Voting, Mergers & Acquisitions, Practitioner Publications, Securities Litigation & Enforcement
Tagged COVID-19, Institutional Investors, Merger litigation, Mergers & acquisitions, Poison pills, Proxy fights, Shareholder activism, SPACs, Takeover defenses
Comments Off on The Activism Vulnerability Report Q4 2020
How Boards Can Get Human Capital Management Right in Five (Not So) Easy Steps
At the outset of the pandemic, employees were the top priority of boards, second only to continued liquidity. That focus intensified during the social unrest following the death of George Floyd. Now, the SEC’s new disclosure rules on human capital management (HCM) could further reinforce the focus on workers—at least temporarily. Boards will soon face […]
Click here to read the complete post